Хайлтын үр дүнгүүд - Arnob Banerjee

Үр дүнг сайжруулах
  1. 1
    Effector, Memory, and Dysfunctional CD8<sup>+</sup>T Cell Fates in the Antitumor Immune Response

    Effector, Memory, and Dysfunctional CD8<sup>+</sup>T Cell Fates in the Antitumor Immune Response -н John Reiser, Arnob Banerjee

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Micro‐RNA‐155 inhibits IFN‐γ signaling in CD4<sup>+</sup> T cells

    Micro‐RNA‐155 inhibits IFN‐γ signaling in CD4<sup>+</sup> T cells -н Arnob Banerjee, Felix Schambach, Caitlin S. DeJong, Scott M. Hammond, Steven L. Reiner

    Хэвлэсэн 2009
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    mTORC1 Promotes T-bet Phosphorylation To Regulate Th1 Differentiation

    mTORC1 Promotes T-bet Phosphorylation To Regulate Th1 Differentiation -н Olesya Chornoguz, Robert S. Hagan, Azeb Haile, Matthew L. Arwood, Christopher Gamper, Arnob Banerjee, Jonathan D. Powell

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Cutting Edge: The Transcription Factor Eomesodermin Enables CD8+ T Cells To Compete for the Memory Cell Niche

    Cutting Edge: The Transcription Factor Eomesodermin Enables CD8+ T Cells To Compete for the Memory Cell Niche -н Arnob Banerjee, Scott M. Gordon, Andrew M. Intlekofer, Michael Paley, Erin C. Mooney, Tulia Lindsten, E. John Wherry, Steven L. Reiner

    Хэвлэсэн 2010
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells

    Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells -н Andrew M. Intlekofer, Naofumi Takemoto, Charlly Kao, Arnob Banerjee, Felix Schambach, John K. Northrop, Hao Shen, E. John Wherry, Steven L. Reiner

    Хэвлэсэн 2007
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Anomalous Type 17 Response to Viral Infection by CD8 <sup>+</sup> T Cells Lacking T-bet and Eomesodermin

    Anomalous Type 17 Response to Viral Infection by CD8 <sup>+</sup> T Cells Lacking T-bet and Eomesodermin -н Andrew M. Intlekofer, Arnob Banerjee, Naofumi Takemoto, Scott M. Gordon, Caitlin S. DeJong, Haina Shin, Christopher A. Hunter, E. John Wherry, Tullia Lindsten, Steven L. Reiner

    Хэвлэсэн 2008
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Teclistamab: Mechanism of action, clinical, and translational science

    Teclistamab: Mechanism of action, clinical, and translational science -н Yue Guo, Natalia A. Quijano Cardé, Lijuan Kang, Raluca Verona, Arnob Banerjee, Rachel Kobos, Katherine Chastain, Clarissa Uhlar, Kodandaram Pillarisetti, Margaret Doyle, Jennifer Smit, Nahor Haddish‐Berhane, Danièle Ouellet

    Хэвлэсэн 2024
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study

    Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study -н Ajay K. Nooka, Cesar Rodriguez, María‐Victoria Mateos, Salomon Manier, Katherine Chastain, Arnob Banerjee, Rachel Kobos, Keqin Qi, Raluca Verona, Margaret Doyle, Thomas G Martin, Niels W.C.J. van de Donk

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY

    S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY -н Fritz Offner, O. Decaux, Cyrille Hulin, Sébastien Anguille, Anne Sophie Michallet, Luciano J. Costa, Cyrille Touzeau, Kevin Boyd, Deeksha Vishwamitra, Yue Guo, Zhuolu Niu, Julie S. Larsen, Lingling Chen, Arnob Banerjee, Jenna D. Goldberg, Jeffrey Matous

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma

    Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma -н Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti, Raluca Verona, Diego Vieyra, Tineke Casneuf, Damien Fink, Xin Miao, Yang Chen, Tara Stephenson, Arnob Banerjee, Brandi Hilder, Jeffery S. Russell, Jeffrey R. Infante, Yusri Elsayed, Jennifer Smit, Jenna D. Goldberg

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma

    Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma -н Thomas G Martin, María‐Victoria Mateos, Ajay K. Nooka, Arnob Banerjee, Rachel Kobos, Lixia Pei, Ming Qi, Raluca Verona, Margaret Doyle, Jennifer Smit, Weili Sun, Danielle Trancucci, Clarissa Uhlar, Niels W.C.J. van de Donk, Cesar Rodriguez

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)

    Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refractory Multip... -н Deepu Madduri, Saad Z. Usmani, Sundar Jagannath, Indrajeet Singh, Enrique Zudaire, Tzu‐Min Yeh, Alicia J. Allred, Arnob Banerjee, Jeffrey L. Goldberg, Jordan M. Schecter, Sen Hong Zhuang, Jeffrey R. Infante, Syed Rizvi, Xiao-Hu Fan, Andrzej Jakubowiak, Jesús G. Berdeja

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma

    Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with r... -н Tom Martin, Saad Z. Usmani, Jordan M. Schecter, Martin Vogel, Carolyn C. Jackson, William Deraedt, Hong Tian, Tzu‐Min Yeh, Arnob Banerjee, Lida Pacaud, Ashraf Garrett, Anja Haltner, Chris Cameron, Suzy Van Sanden, Joris Diels, Satish Valluri, Imtiaz A. Samjoo

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow

    T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow -н Craig N. Jenne, Anselm Enders, Richard Rivera, Susan R. Watson, Alexander J. Bankovich, João P. Pereira, Ying Xu, Carla M. Roots, Joshua Beilke, Arnob Banerjee, Steven L. Reiner, Sara A. Miller, Amy S. Weinmann, Christopher C. Goodnow, Lewis L. Lanier, Jason G. Cyster, Jerold Chun

    Хэвлэсэн 2009
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM)

    Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM) -н Alfred L. Garfall, Saad Z. Usmani, María‐Victoria Mateos, Hareth Nahi, Niels W.C.J. van de Donk, Jesús F. San Miguel, Albert Oriol Rocafiguera, Laura Rosiñol, Ajai Chari, Manisha Bhutani, Lixia Pei, Raluca Verona, Suzette Girgis, Tara Stephenson, Jenna D. Goldberg, Arnob Banerjee, Amrita Krishnan

    Хэвлэсэн 2020
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1

    Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1 -н Xin Miao, Liviawati S. Wu, Shun Xin Wang Lin, Yan Xu, Yang Chen, Yuki Iwaki, Rachel Kobos, Tara Stephenson, Kristy Kemmerer, Clarissa Uhlar, Arnob Banerjee, Jenna D. Goldberg, Danielle Trancucci, Amit Apte, Raluca Verona, Lixia Pei, Rachit Desai, Kathleen T. Hickey, Yaming Su, Danièle Ouellet, Mahesh N. Samtani, Yue Guo, Alfred L. Garfall, Amrita Krishnan, Saad Z. Usmani, Honghui Zhou, Suzette Girgis

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

    CAR+ T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma -н Simon J. Harrison, Tamia Nguyen, Marzia Rahman, Jeremy Er, Jessica Li, Katherine Li, Nikoletta Lendvai, Jordan M. Schecter, Arnob Banerjee, Tito Roccia, Brad Foulk, Junchen Gu, Hao Zhao, Denis A. Smirnov, Ana Slaughter, Carolina Lonardi, Erin Lee, Loreta Marquez, Shirin Jadidi, Octavio Costa Filho, Nitin Patel, Dong Geng, Nicole M. Haynes, Hannah G. Kelly, Stephen Lade, Sean M. Grimmond, Piers Blombery

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

    Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study -н Diana Cortés‐Selva, Tatiana Perova, Sheri Skerget, Deeksha Vishwamitra, Sarah Stein, Rengasamy Boominathan, On Say Lau, Karl C. Nielsen, Cuc Davis, Jaymala Patel, Arnob Banerjee, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Jenna D. Goldberg, Lixia Pei, Danielle Trancucci, Suzette Girgis, Shun Xin Wang Lin, Liviawati S. Wu, Philippe Moreau, Saad Z. Usmani, Nizar J. Bahlis, Niels W.C.J. van de Donk, Raluca Verona

    Хэвлэсэн 2024
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation

    Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation -н Kristine A. Frerichs, Christie P.M. Verkleij, María‐Victoria Mateos, Thomas G. Martin, Cesar Rodriguez, Ajay K. Nooka, Arnob Banerjee, Katherine Chastain, Alfredo Perales‐Puchalt, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Bronno van der Holt, Sandy Kruyswijk, Maria T. Kuipers, Kaz Groen, Deeksha Vishwamitra, Sheri Skerget, Diana Cortés‐Selva, Margaret Doyle, Hans L. Zaaijer, Sonja Zweegman, Raluca Verona, Niels W.C.J. van de Donk

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma

    Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Rela... -н Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja, Andrzej Jakubowiak, Mounzer Agha, Adam D. Cohen, Parameswaran Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander M. Lesokhin, Nikhil C. Munshi, Elizabeth O’Donnell, A. Keith Stewart, Jordan M. Schecter, Jeffrey L. Goldberg, Carolyn C. Jackson, Tzu‐Min Yeh, Arnob Banerjee, Alicia J. Allred, Enrique Zudaire, William Deraedt, Deepu Madduri, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Yi Lin, Sundar Jagannath

    Хэвлэсэн 2021
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: